David W. Ollila

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

Lisa A. Carey, Elizabeth Claire Dees, Lynda Sawyer et al. · Clinical Cancer Research · 2007 · 2.1K citations · Full text

Medicine, Oncology, Breast Oncology +14

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

Armando E. Giuliano, Karla V. Ballman, Linda McCall et al. · JAMA · 2017 · 1.9K citations · Full text

Medicine, Oncology, Surgery +16

Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma

Roderick R. Turner, David W. Ollila, David L. Krasne et al. · Annals of Surgery · 1997 · 618 citations

Medicine, Pathology, Surgery +16

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

Lisa A. Carey, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2015 · 437 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study

Nancy E. Thomas, Klaus J. Busam, Lynn From et al. · Journal of Clinical Oncology · 2013 · 275 citations · Full text

Veterinary Medicine, Oncology, Pathology +17